SF
CRL icon

Synovus Financial’s Charles River Laboratories CRL Stock Holding History

Synovus Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-303
Closed -$39K – 1663
2020
Q1 		$39K Buy
+303
New +$45.4K ﹤0.01% 1178
2015
Q1 		– Sell
-105
Closed -$7K – 1036
2014
Q4 		$7K Buy
+105
New +$6.58K ﹤0.01% 912

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Synovus Financial's CRL Position: Q2 2020 in Review

Synovus Financial sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 303 shares — an estimated $39K sold.

Synovus Financial first reported a position in CRL in Q4 2014 and held it in 2 quarters. The position peaked at $39K in Q1 2020. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Synovus Financial reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 303 Charles River Laboratories shares in Q2 2020, an estimated $39K.
  • Synovus Financial first reported a position in Charles River Laboratories in Q4 2014 and held it in 2 quarters.
  • Synovus Financial's Charles River Laboratories position peaked at $39K in Q1 2020.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.